The HLA-DRB1*0401 Allele and the Development of Methotrexate-Induced Accelerated Rheumatoid Nodulosis
Authors:
- Frank C. ArnettFAFrank C. Arnett
- Carolyn A. SmithCSCarolyn A. Smith
- Chul AhnCAChul Ahn
- John D. ReveilleJRJohn D. Reveille
- 1 July 2001
- journal article
- Published by Wolters Kluwer Health in Medicine
- Vol. 80 (4) , 271-278
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Colchicine Therapy for Low‐Dose‐Methotrexate‐Induced Accelerated Nodulosis in a Rheumatoid Arthritis PatientThe Journal of Dermatology, 1999
- Accelerated Nodulosis During Methotrexate Therapy for Refractory Rheumatoid Arthritis1999
- Methotrexate‐associated appearance and rapid progression of rheumatoid nodules in systemic‐onset juvenile rheumatoid arthritisArthritis & Rheumatism, 1997
- HLA CLASS 2 GENES IN SINGAPOREAN CHINESE RHEUMATOID ARTHRITISRheumatology, 1994
- The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.Journal of Clinical Investigation, 1993
- Nonperipheral accelerated nodulosis in a methotrexate‐treated rheumatoid arthritis patientArthritis & Rheumatism, 1993
- DNA typing for class II HLA antigens with allele-specific or group-specific amplification. I. Typing for subsets of HLA-DR4Human Immunology, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.Annals of the Rheumatic Diseases, 1983
- A general method for isolation of high molecular weight DNA from eukaryotesNucleic Acids Research, 1976